Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
Headline: Federal Tariffs on Chinese Products Raised to 20 Percent
What it does: Federal agencies must implement a 20 percent ad valorem tariff on articles that are products of the People's Republic of China.
- Raises duty on covered Chinese products from 10 percent to 20 percent.
- Directs federal agencies to apply ad valorem tariffs to goods made in China.
- Affects importers and businesses trading in the impacted Chinese products.
Summary
This order increases tariffs on certain imports from the People's Republic of China, raising the rate from 10 percent to 20 percent for covered articles. It amends a prior order that imposed duties to address the flow of synthetic opioids, including fentanyl, from China to the United States.
The change affects goods that are products of China and directs federal agencies to implement the higher ad valorem tariffs. The administration says the measure responds to China’s failure to curb the illicit drug supply and aims to protect U.S. national security, foreign policy, and the economy.
Ask about this order
Ask questions about this executive order and its implications.
What agencies are affected by this order?
How does this order change existing policy?
What are the practical implications of this order?